HARROW, INC. — Director's Dealing 2013

Mar 16, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-12-31

Reporting Person: BAUM MARK L (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-28	Common Stock	C	1454962	—	Acquired	0	Indirect
2012-04-30	Common Stock	J	193047	$762534	Acquired	0	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-01	Convertible Debenture	$0.6668	P	856087	Acquired	2012-04-05	Common Stock (1454962)	Indirect
2012-02-28	Convertible Debenture	$0.6668	C	856087	Disposed	2012-04-05	Common Stock (1454962)	Indirect
2012-02-28	Option (Right to Buy)	$2.4	A	125000	Acquired	2022-01-24	Common Stock (125000)	Direct
2012-04-01	Option (Right to Buy)	$4.5	A	60000	Acquired	2017-03-31	Common Stock (60000)	Direct
2012-04-01	Option (Right to Buy)	$4.5	A	25000	Acquired	2017-03-31	Common Stock (25000)	Direct
2012-04-30	Warrants	$5.925	P	48262	Acquired	2015-04-29	Common Stock (48262)	Indirect
2012-07-12	Warrants	$5.925	J	2413	Acquired	2015-04-20	Common Stock (2413)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	169385	Direct

Footnotes

F1: Represents the shares of common stock acquired by DermaStar International, LLC ("DermaStar") upon automatic conversion of a convertible debenture issued by the Issuer on April 5, 2010 and acquired by DermaStar in a private transaction on January 1, 2012.

F2: Reporting person was a managing member of DermaStar at the time of the reported transaction and may be deemed to have voting and dispositive power over such shares. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. As previously reported on a Form 4 filed on July 20, 2012, on July 12, 2012 DermaStar distributed to its members all securities of the Issuer held by it and was subsequently dissolved.

F3: The stock options were granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vest over a 1 year period, with 1/12 of the total number of options vesting each monthly period following the grant date of the issuance of such options. The option was approved by the Issuer's Board of Directors on January 1, 2012, subject to shareholder approval of an amendment to the Plan, which was obtained on February 28, 2012.

F4: The stock options were granted under the Plan and vest over a 2 year period, with 15,000 options vesting immediately upon issuance, and an additional 1,875 options vesting monthly for the next twenty four months thereafter.

F5: The stock options were granted under the Plan and vest over a 1 year period, with the initial 6,250 options vesting on June 30, 2012, the next 6,250 options vesting on September 30, 2012, the next 6,250 options vesting on December 31, 2012 and the final 6,250 options vesting on March 31, 2013.

F6: Represents shares received upon the exchange of amounts owing under an outstanding Line of Credit into common stock of the Issuer.

F7: Represents warrants distributed by DermaStar to its members on July 12, 2012.